The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
Texas MPN Workshop 2022 | The importance of studying patient-reported outcomes in MPNs
Lucia Masarova, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the importance of evaluating patient-reported outcomes in myeloproliferative neoplasms (MPNs), and further highlights the value of implementing questionnaires and other methods of assessing these outcomes in clinical trials and in clinical practice. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.
